Abstract:Background Gammadelta T cells represent a minor population of human peripheral blood T lymphocytes. As very rapid cytokine-producing cells, gammadelta T cells can regulate other lymphocytes activation and assist their local inflammatory function, thus are involved in some autoimmune diseases. Systemic lupus erythematosus (SLE) is a multi-organ damage autoimmune disease characterized by lymphocytes dysfunction and aberrant cytokines production. Objectives The aim of this study was to detect gammadelta T cells numbers in the peripheral blood mononuclear cells (PBMCs) and analyze their intracellular cytokines profile (IFN-γ, IL-4, IL-10, IL-17, TGF-β). Methods Gammadelta T cells were detected in peripheral blood from 42 SLE patients and 20 normal controls by flow cytometry (FACS). Lupus disease activity was evaluated with a SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) score. Active SLE was defined as SLEDAI≥8. Anniex-V/PI double-staining FACS analysis was employed to observe the proportion of the apoptotic gammadelta T cellsin 6 active SLE patients and 6 normal controls, respectively. The percentages of cytoplasmic cytokines including IFN-γ, IL-4, IL-10, IL-17 and TGF-β were examined in20 SLE patients and 10 normal controls by using FACS anlysis. Results The percentages of gammadelta T cells were remarkably down-regulated in active SLE patients (2.96±1.84%, n=30) compared with that of inactive (5.31±3.05%, n=12) and normal controls (6.83±2.85%, n=20, both p<0.01). The absolute number of gammadelta T cells decreased significantly in active SLE patients (1.72±1.58×107/L, n=30) than that in inactive SLE (5.27±3.60×107/L, n=12, p<0.01), both lower than in normal controls (10.07±4.99 ×107/L, n=20, both p<0.01). There was increased gammadelta T cells apoptosis (17.03±8.71%, n=6) in SLE patients than in normal controls (6.67±1.18%, n=6, p<0.05). The positive rate of gammadelta T intracellular IFN-γ, IL-4, IL-10 and TGF-β production in 20 SLE patients were 33.19±20.20%, 1.04±0.93%, 1.91±0.98% and 2.20±1.97%, significantly higher than that of 10 normal controls (IFN-γ: 5.87±4.63%, IL-4:0.30±0.34%, IL-10:0.18±0.31%, TGF-β: 0.21±0.22%, all p<0.01). While there were no differences in the percentages of IL-17-positive gammadelta T cells between SLE patients (0.14±0.24%, n=20) and normal controls (0.18±0.31%, n=10). Conclusions Gammadelta T cells are down-regulated in SLE partly due to excessive apoptosis. GammadeltaT cells secret both pro- and anti-inflammatory cytokinesin SLE microenvironment, suggesting these cells participate in both the regulation and the propagation of lupus. Disclosure of Interest None Declared

Decreased Gαq Expression in T Cells Correlates with Enhanced Cytokine Production and Disease Activity in Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Elevated Apoptosis and Impaired Proliferation Contribute to Downregulated PeripheralγδT Cells in Patients with Systemic Lupus Erythematosus

Abnormal lower expression of GPR183 in peripheral blood T and B cell subsets of systemic lupus erythematosus patients

Abnormal Th Cell Differentiation Associated Gene Expression in Systemic Lupus Erythematosus Patients

Th22, but not Th17 Might be a Good Index to Predict the Tissue Involvement of Systemic Lupus Erythematosus

Gαq Controls Rheumatoid Arthritis Via Regulation of Th17 Differentiation

Circulating CD8 + LGALS9 + T Cell Population Exhibiting Low Cytotoxic Characteristics are Decreased in Patients with Systemic Lupus Erythematosus

Upregulation of Granzyme B and C-X3-C Motif Receptor 1 in Circulating Plasmablasts Was Negatively Regulated by Notch Signal in Patients with Systemic Lupus Erythematosus.

Change and clinical significance of peripheral blood γδT cells in patients with systemic lupus erythematosus

Deficiency of the G Protein Gαq Ameliorates Experimental Autoimmune Encephalomyelitis with Impaired DC-derived IL-6 Production and Th17 Differentiation.

118 Granzyme B Producing B Cells in Systemic Lupus Erythematosus Patients and Lupus-Like Mouse Models

Upregulation of CX3CR1 expression in circulating T cells of systemic lupus erythematosus patients as a reflection of autoimmune status through characterization of cytotoxic capacity

Impaired Granzyme B-producing Regulatory B Cells in Systemic Lupus Erythematosus

Downregulation of CD94/NKG2A Inhibitory Receptor on Decreased Γδ T Cells in Patients with Systemic Lupus Erythematosus.

AB0063 Gammadelta T Cells and Their Intracellular Cytokine Profile in Peripheral Blood of Patients with Systemic Lupus Erythematosus

Impaired regulatory function of granzyme B-producing B cells against T cell inflammatory responses in lupus mice

Decreased Expressions of the TNF-alpha Signaling Adapters in Peripheral Blood Mononuclear Cells (pbmcs) Are Correlated with Disease Activity in Patients with Systemic Lupus Erythematosus

Loss of Gαq Impairs Regulatory B-cell Function

[The Expression and Significance of Microtubule-Associated Protein 1 Light Chain 3-Related Protein-1 (LC3) Mrna in Peripheral Blood Mononuclear Cells in Patients with Systemic Lupus Erythematosus].